Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Non-Current ReceivablesReceivables - NetReceivables - Other
Ratios

Dr Reddys Laboratories (RDY) Receivables Refunds (2017 - 2023)

Dr Reddys Laboratories (RDY) has 7 years of Receivables Refunds data on record, last reported at $32.7 million in Q1 2023.

  • For Q1 2023, Receivables Refunds fell 39.09% year-over-year to $32.7 million; the TTM value through Mar 2023 reached $32.7 million, down 39.09%, while the annual FY2023 figure was $33.5 million, 38.17% down from the prior year.
  • Receivables Refunds reached $32.7 million in Q1 2023 per RDY's latest filing, down from $53.7 million in the prior quarter.
  • Across five years, Receivables Refunds topped out at $60.4 million in Q1 2020 and bottomed at $32.7 million in Q1 2023.
  • Average Receivables Refunds over 5 years is $46.5 million, with a median of $48.2 million recorded in 2019.
  • Peak YoY movement for Receivables Refunds: soared 42.54% in 2022, then plummeted 39.09% in 2023.
  • A 5-year view of Receivables Refunds shows it stood at $48.2 million in 2019, then increased by 25.42% to $60.4 million in 2020, then plummeted by 37.72% to $37.6 million in 2021, then surged by 42.54% to $53.7 million in 2022, then plummeted by 39.09% to $32.7 million in 2023.
  • Per Business Quant database, its latest 3 readings for Receivables Refunds were $32.7 million in Q1 2023, $53.7 million in Q1 2022, and $37.6 million in Q1 2021.